Literature DB >> 10655093

Does Alzheimer disease tilt the scales of amyloid degradation versus accumulation?

C Glabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10655093     DOI： 10.1038/72215

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  Bivalent ligand containing curcumin and cholesterol as fluorescence probe for Aβ plaques in Alzheimer's disease.

Authors:  Kai Liu; Tai L Guo; Jeremy Chojnacki; Hyoung-Gon Lee; Xinglong Wang; Sandra L Siedlak; Wei Rao; Xiongwei Zhu; Shijun Zhang
Journal:  ACS Chem Neurosci       Date:  2011-12-11       Impact factor: 4.418

2.  Altered NEP2 expression and activity in mild cognitive impairment and Alzheimer's disease.

Authors:  Jeffrey Y Huang; Daniel M Hafez; Bryan D James; David A Bennett; Robert A Marr
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Aging-related correlation of insulin-degrading enzyme with gamma-secretase-generated products involving insulin and glucose levels in transgenic mice.

Authors:  Dae Y Hwang; Jung S Cho; Chuel K Kim; Sun B Shim; Seung W Jee; Su H Lee; Su J Seo; Joon Y Cho; Seok H Lee; Yong K Kim
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

4.  ANCA: A Family of Fluorescent Probes that Bind and Stain Amyloid Plaques in Human Tissue.

Authors:  Willy M Chang; Marianna Dakanali; Christina C Capule; Christina J Sigurdson; Jerry Yang; Emmanuel A Theodorakis
Journal:  ACS Chem Neurosci       Date:  2011-05-18       Impact factor: 4.418

5.  Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain.

Authors:  M Nistor; M Don; M Parekh; F Sarsoza; M Goodus; G E Lopez; C Kawas; J Leverenz; E Doran; I T Lott; M Hill; E Head
Journal:  Neurobiol Aging       Date:  2006-08-09       Impact factor: 4.673

6.  Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1.

Authors:  I Dewachter; J Van Dorpe; L Smeijers; M Gilis; C Kuipéri; I Laenen; N Caluwaerts; D Moechars; F Checler; H Vanderstichele; F Van Leuven
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

7.  Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis.

Authors:  Tricia A Thornton-Wells; Jason H Moore; Eden R Martin; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Genet Epidemiol       Date:  2008-04       Impact factor: 2.135

8.  Impact of aging: sporadic, and genetic risk factors on vulnerability to apoptosis in Alzheimer's disease.

Authors:  Katharina Schindowski; Tilmann Kratzsch; Jürgen Peters; Barbara Steiner; Silke Leutner; Natalie Touchet; Konrad Maurer; Christian Czech; Laurent Pradier; Lutz Frölich; Walter E Müller; Anne Eckert
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

9.  Estrogen regulation of the neprilysin gene through a hormone-responsive element.

Authors:  Zhi-Min Xiao; Li Sun; Yu-Min Liu; Jun-Jian Zhang; Jian Huang
Journal:  J Mol Neurosci       Date:  2009-01-06       Impact factor: 3.444

10.  Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.

Authors:  Robert A Marr; Edward Rockenstein; Atish Mukherjee; Mark S Kindy; Louis B Hersh; Fred H Gage; Inder M Verma; Eliezer Masliah
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.